In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Anebulo Pharmaceuticals Inc (NASDAQ: ANEB) was $1.2 for the day, up 0.84% from the previous closing price of $1.19. In other words, the price has increased by $0.84 from its previous closing price. On the day, 61948.0 shares were traded. ANEB stock price reached its highest trading level at $1.23 during the session, while it also had its lowest trading level at $1.15.
Ratios:
Our analysis of ANEB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.93 and its Current Ratio is at 10.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANEB now has a Market Capitalization of 49301680 and an Enterprise Value of 38946904.
Stock Price History:
The Beta on a monthly basis for ANEB is -0.86, which has changed by -0.26543212 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, ANEB has reached a high of $3.42, while it has fallen to a 52-week low of $0.90. The 50-Day Moving Average of the stock is -49.33%, while the 200-Day Moving Average is calculated to be -37.73%.
Shares Statistics:
ANEB traded an average of 45.37K shares per day over the past three months and 178800 shares per day over the past ten days. A total of 41.08M shares are outstanding, with a floating share count of 24.43M. Insiders hold about 40.54% of the company’s shares, while institutions hold 54.08% stake in the company. Shares short for ANEB as of 1764288000 were 121417 with a Short Ratio of 2.58, compared to 1761868800 on 163504. Therefore, it implies a Short% of Shares Outstanding of 121417 and a Short% of Float of 1.7500000000000002.
Earnings Estimates
The stock of Anebulo Pharmaceuticals Inc (ANEB) is currently in the spotlight, with 1.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.14 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.48 and -$0.48 for the fiscal current year, implying an average EPS of -$0.48. EPS for the following year is -$0.46, with 1.0 analysts recommending between -$0.46 and -$0.46.
